000 01416 a2200385 4500
005 20250511215913.0
264 0 _c19910522
008 199105s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19910515)67:10<2459::aid-cncr2820671011>3.0.co;2-l
_2doi
040 _aNLM
_beng
_cNLM
100 1 _adel Giglio, A
245 0 0 _aSevere, symptomatic, dose-limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases.
_h[electronic resource]
260 _bCancer
_cMay 1991
300 _a2459-61 p.
_bdigital
500 _aPublication Type: Case Reports; Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHepatic Artery
650 0 4 _aHumans
650 0 4 _aInfusions, Intra-Arterial
650 0 4 _aLiver Neoplasms
_xsecondary
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhosphates
_xblood
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aTumor Necrosis Factor-alpha
_xadministration & dosage
700 1 _aZukiwski, A A
700 1 _aAli, M K
700 1 _aMavligit, G M
773 0 _tCancer
_gvol. 67
_gno. 10
_gp. 2459-61
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19910515)67:10<2459::aid-cncr2820671011>3.0.co;2-l
_zAvailable from publisher's website
999 _c2021728
_d2021728